Brainstorm Historical Cash Flow
BCLI Stock | USD 1.71 0.03 1.72% |
Analysis of Brainstorm Cell cash flow over time is an excellent tool to project Brainstorm Cell Ther future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 733.4 K or Other Cashflows From Financing Activities of 2.2 M as it is a great indicator of Brainstorm Cell ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Brainstorm Cell Ther latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Brainstorm Cell Ther is a good buy for the upcoming year.
Brainstorm |
About Brainstorm Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Brainstorm balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Brainstorm's non-liquid assets can be easily converted into cash.
Brainstorm Cell Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Depreciation
Depreciation indicates how much of Brainstorm Cell Ther value has been used up. For tax purposes Brainstorm Cell can deduct the cost of the tangible assets it purchases as business expenses. However, Brainstorm Cell Therapeutics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Brainstorm Cell's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Brainstorm Cell Ther current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. As of now, Brainstorm Cell's Other Cashflows From Investing Activities is increasing as compared to previous years. The Brainstorm Cell's current Investments is estimated to increase to about 3.2 M, while Free Cash Flow is projected to decrease to (21.5 K).
Brainstorm Cell cash flow statement Correlations
Click cells to compare fundamentals
Brainstorm Cell Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Brainstorm Cell cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (406K) | 37.3M | (19.0M) | (18.1M) | 713K | 748.7K | |
Free Cash Flow | (11.7M) | (35.6M) | (26.6M) | (19.3M) | (20.5K) | (21.5K) | |
Change In Working Capital | 11.1M | (6.2M) | (3.4M) | 3.0M | (3.8M) | (3.6M) | |
Begin Period Cash Flow | 942K | 536K | 37.8M | 18.9M | 772K | 733.4K | |
Other Cashflows From Financing Activities | 3.2M | 16.3M | 5K | 998K | 2.2M | 2.2M | |
Depreciation | 164K | 219K | 260K | 285K | 265K | 231.9K | |
Other Non Cash Items | 25K | 161K | 3.3M | (1.3M) | 220K | 209K | |
Capital Expenditures | 473K | 378K | 330K | 29K | 18K | 17.1K | |
Total Cash From Operating Activities | (11.2M) | (35.2M) | (26.3M) | (19.3M) | (20.5M) | (19.4M) | |
Net Income | (23.3M) | (31.8M) | (24.5M) | (24.3M) | (17.2M) | (16.3M) | |
Total Cash From Financing Activities | 5.2M | 76.9M | 7.0M | 238K | 19.0M | 19.9M | |
End Period Cash Flow | 536K | 37.8M | 18.9M | 772K | 1.5K | 1.4K | |
Sale Purchase Of Stock | 12.1M | 3.2M | (116K) | 5K | 4.5K | 4.3K | |
Stock Based Compensation | 764K | 2.6M | 1.4M | 1.7M | 1.5K | 1.4K | |
Change To Account Receivables | 690K | 1.5M | 335K | 1.1M | (475.0) | (451.25) | |
Total Cashflows From Investing Activities | 5.6M | (4.5M) | 323K | 998K | 1.1M | 1.2M | |
Investments | 6.1M | (4.1M) | 653K | 998K | 3.0M | 3.2M | |
Change Receivables | (238K) | 690K | 1.5M | 335K | 385.3K | 404.5K | |
Cash And Cash Equivalents Changes | (1.5M) | (406K) | 37.3M | (19.0M) | (21.8M) | (20.7M) | |
Change To Netincome | 789K | 2.6M | 1.4M | 1.7M | 1.9M | 1.4M | |
Change To Liabilities | 10.2M | (7.8M) | (1.7M) | 2.5M | 2.9M | 3.0M | |
Change To Operating Activities | 234K | 1.6M | (2.1M) | (601K) | (540.9K) | (513.9K) |
Currently Active Assets on Macroaxis
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.45) | Return On Assets (1.78) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.